CELCUITY INC. Active Patents
9 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2023-01-23: Application 18100437; Invention METHODS OF PREPARING A PRIMARY CELL SAMPLE; Applicant Celcuity Inc.; Status Patented Case.
- 2022-07-25: Application 17872721; Invention METHODS FOR THE TREATMENT OF CANCER USING 1-(4-{[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]CARBONYL}PHENYL)-3-[4-(4,6-DIMORPHOLIN-4-YL-1,3,5-TRIAZIN-2-YL)PHENYL]UREA; Applicant Celcuity Inc.; Status Patented Case.
- 2022-04-13: Application 17720067; Invention METHODS OF MEASURING SIGNALING PATHWAY ACTIVITY FOR SELECTION OF THERAPEUTIC AGENTS; Applicant Celcuity Inc.; Status Patented Case.
- 2018-08-29: Application 16116392; Invention METHODS OF MEASURING SIGNALING PATHWAY ACTIVITY FOR SELECTION OF THERAPEUTIC AGENTS; Applicant Celcuity Inc.; Status Patented Case.
| Filed | Application | Invention | Applicant | Status | Granted | Patent | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-23 | 18100437 | METHODS OF PREPARING A PRIMARY CELL SAMPLE | Celcuity Inc. | Patented Case | 2025-02-04 | 12215356 | US20230235293A1 | Lance Gavin LAING Ben RICH Abhijit DANDAPAT | United States United States United States | CONNORS, ALEXANDRA F |
| 2022-07-25 | 17872721 | METHODS FOR THE TREATMENT OF CANCER USING 1-(4-{[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]CARBONYL}PHENYL)-3-[4-(4,6-DIMORPHOLIN-4-YL-1,3,5-TRIAZIN-2-YL)PHENYL]UREA | Celcuity Inc. | Patented Case | 2025-07-08 | 12350276 | US20230022525A1 | Brian Francis SULLIVAN Lance Gavin LAING | United States United States | ABDALHAMEED, MANAHIL MIRGHANI ALI |
| 2022-04-13 | 17720067 | METHODS OF MEASURING SIGNALING PATHWAY ACTIVITY FOR SELECTION OF THERAPEUTIC AGENTS | Celcuity Inc. | Patented Case | 2025-06-03 | 12320799 | US20230125427A1 | Lance Gavin LAING Brian Francis SULLIVAN | United States United States | COOK, LISA V |
| 2018-08-29 | 16116392 | METHODS OF MEASURING SIGNALING PATHWAY ACTIVITY FOR SELECTION OF THERAPEUTIC AGENTS | Celcuity Inc. | Patented Case | 2022-05-17 | 11333659 | US20190025287A1 | Lance Gavin LAING Brian Francis SULLIVAN | United States United States | COOK, LISA V |
| 2018-07-03 | 16027073 | WHOLE CELL ASSAYS AND METHODS | Celcuity Inc. | Patented Case | 2021-04-13 | 10976307 | US20180321222A1 | Lance Gavin LAING Brian Francis SULLIVAN | United States United States | DINES, KARLA A |
| 2018-04-11 | 15950739 | METHODS OF PREPARING A PRIMARY CELL SAMPLE | Celcuity Inc. | Patented Case | 2023-02-28 | 11591573 | US20180230434A1 | Lance Gavin LAING Ben RICH Abhijit DANDAPAT | United States United States United States | CONNORS, ALEXANDRA F |
| 2016-06-24 | 15192280 | WHOLE CELL ASSAYS AND METHODS | Celcuity LLC | Patented Case | 2018-08-07 | 10041934 | US20160305932A1 | Lance Gavin LAING Brian Francis SULLIVAN | United States United States | DINES, KARLA A |
| 2016-06-10 | 15179119 | ASSAYS AND METHODS FOR DETERMINING THE RESPONSIVENESS OF AN INDIVIDUAL SUBJECT TO A THERAPEUTIC AGENT | Celcuity Inc. | Patented Case | 2021-07-27 | 11073509 | US20170067875A1 | Lance Gavin LAING Brian Francis SULLIVAN | United States United States | CANELLA, KAREN A |
| 2015-01-06 | 14590731 | WHOLE CELL ASSAYS AND METHODS | Celcuity LLC | Patented Case | 2016-08-02 | 9404915 | US20150125894A1 | Lance Gavin LAING Brian Francis SULLIVAN | United States United States | DINES, KARLA A |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |